76 results
Page 3 of 4
6-K
EX-99.1
b7p7gpd2 xkrqgv8ob90
8 May 20
MorphoSys Reports First Quarter 2020 Results
6:25am
6-K
EX-99.1
fvo6h 806c
24 Apr 20
MorphoSys Appoints Roland Wandeler, Ph.D., as Chief Commercial Officer
11:02am
6-K
EX-99.1
pn1kgl
27 Mar 20
Current report (foreign)
3:29pm
6-K
EX-99.1
k7atq9nmwe67b7d
20 Mar 20
Current report (foreign)
2:15pm
6-K
EX-99.2
myeq2d8dpvfvf2ydmjm7
20 Mar 20
MorphoSys Presents Results for Fiscal Year 2019
6:24am
6-K
EX-99.1
pqbd frca3meq2
3 Dec 19
Announces His Departure
8:42am
6-K
EX-99.2
ysgew7 s6v0
9 Aug 19
Current report (foreign)
6:18am
6-K
EX-99.1
vj8gem7mpt
9 Aug 19
Current report (foreign)
6:18am
6-K
EX-99.2
23537j 6j
8 Aug 19
Half-Year Report January – June 2019
6:38am
6-K
EX-99.1
r0kwy2jns 8d68ml7li2
26 Jun 19
Current report (foreign)
6:17am
6-K
EX-99.2
sfn4jhzzccb bk
26 Jun 19
Current report (foreign)
6:17am
6-K
EX-99.1
se1 c1dku5
21 Mar 19
Current report (foreign)
6:14am
6-K
EX-99.1
tq6phobnq2t31i
15 Mar 19
2018 annual report Morphosys Engineering the Medicines of Tomorrow
6:27am
20-F
g4r 7g2aqj7ier
13 Mar 19
Annual report (foreign)
5:13pm
6-K
EX-99.2
zfc3148srb
19 Feb 19
Current report (foreign)
9:51am
6-K
EX-99.1
p9c0owo6zhtw2k99h00
19 Feb 19
Current report (foreign)
9:51am
6-K
EX-99.1
mqq2s2vz
7 Feb 19
MorphoSys Announces Appointment of David Trexler as President
6:18am
6-K
EX-99.1
dsblsq6 3fpp1br
6 Nov 18
MorphoSys AG Announces Third Quarter 2018 Results
11:40am
6-K
EX-99.1
21tn183k 3k028l0318g
2 Nov 18
MorphoSys to Present Data on Investigational Drugs MOR208 and MOR202 in Various Blood Cancer Indications at ASH 2018 Meeting
8:19am